The academic forum "Leading the Micro World, Building Human Beauty and Health - Microsphere Technology and Clinical Applications" was successfully held

On the afternoon of April 2, 2023, the "Leading the Micro World, Building Human Beauty and Health - Microsphere Technology and Clinical Applications" academic forum hosted by Sichuan Maikelong Biotechnology Co., Ltd. was held at the Hyatt Jiaxuan Hotel in Chengdu Tianfu International Biological City.

Chu Liangyin, vice president of Sichuan University, presided over the forum and delivered a keynote speech. Chen Lei, vice president of West China Hospital of Sichuan University, Yang Li, director of the Department of Gastroenterology of West China Hospital of Sichuan University, Li Lin, director of the Department of Nuclear Medicine of West China Hospital of Sichuan University, Wang Hang, chief of the Department of Medical Beauty of West China Stomatological Hospital of Sichuan University, and Sun Kaoxiang, vice president of Nuoqiao Long effect and Slow release Platform attended the meeting and delivered a keynote speech. Professor Ju Xiaojie, head of the Department of Biotechnology and Pharmacy of chemical engineering College of Sichuan University, Wang Wei, assistant dean of chemical engineering College of Sichuan University, Luo Xuefeng, West China Hospital of Sichuan University and other professors attended the forum. At the same time, Sichuan Maikelong Biotechnology Co., Ltd. also invited dozens of experts from industrial enterprises, representatives of Biocity Investment Group, senior technology industry investors, etc. to participate in this forum.

Professor Chu Liangyin from Sichuan University

Professor Chu Liangyin systematically introduced the application and advantages of microfluidic technology in the design and construction of single emulsion, multi emulsion, multi chamber lotion templates and the preparation of functional microparticles by using lotion templates, combined with many years of scientific research experience and scientific research achievements, and looked forward to the application of microparticles in the fields of biomedicine, medical devices, etc.

Professor Chen Lei from West China Hospital of Sichuan University

Professor Chen Lei gave an academic report on the theme of "New Strategies for Diagnosis and Treatment of Epilepsy and Comorbidities", and shared the concept, social impact, and current clinical diagnosis and treatment difficulties of epilepsy based on her years of research and clinical experience. The report points out that the field of epilepsy needs to closely integrate the core perspectives of precision medicine, such as the application of high-end technologies such as microchip detection and microsphere microcapsule sustained-release drugs to the daily diagnosis and drug treatment of epilepsy, truly achieving scientific management of the disease with minimal medical resources, benefiting both doctors and patients.

Professor Sun Kaoxiang, Vice President of Nuoqiao Long term and Controlled Release Platform

Professor Sun Kaoxiang introduced the development process and experience of long-acting injection microspheres based on clinical needs, and shared the unremitting efforts of Green Leaf Group in the field of microspheres.

Professor Yang Li from West China Hospital of Sichuan University

Professor Yang Li introduced in detail the basic concept of TACE, the basic process of interventional surgery, the advantages and disadvantages of commonly used microsphere embolic agents in clinical practice, and the selection of embolic agents based on the application of microspheres in the field of tumor intervention, with the intervention treatment of solid tumors as the starting point.

Professor Wang Hang from West China Stomatological Hospital of Sichuan University

Professor Wang Hang systematically summarized the types, advantages and disadvantages of the materials used in the current market products from the regenerative medical beauty materials and products used in the clinic, and focused on the advantages and disadvantages of the market products and the clinical practical effects of the regenerative medical beauty products.

Professor Li Lin from West China Hospital of Sichuan University

Starting from the national support policy for nuclear medicine, Professor Li Lin shared the current research hotspots in the field of nuclear medicine, and systematically introduced the application of microspheres in nuclide targeted delivery and the significant progress made by his team in the field of nuclide labeled microspheres in recent years. He summarized the future development direction of radiotherapy microspheres.

This forum mainly focused on the technological advantages of intelligent microsphere manufacturing and the application of microspheres in fields such as long-term slow-release preparations for chronic diseases, tumor interventional embolization, radiotherapy microspheres, and tissue regeneration. The attendees had a thorough discussion and showcased the significant application potential of microspheres in biomedicine, medical devices, and other fields.

Zhang Chuan, General Manager of Sichuan Maikelong Biotechnology Co., Ltd., stated that Maikelong will adhere to the mission of "using breakthrough technology to create breakthrough products", with the vision of "leading the forefront of micro world technology, building the beauty and health of human life", and work together with his alma mater and partners from all walks of life to promote technological progress and the leapfrog development of the microfluidic industry.